BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33111378)

  • 1. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India.
    Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients.
    Shah SA; Paradkar M; Desai D; Ashavaid TF
    J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity.
    Shah SAV; Paradkar MU; Desai DC; Ashavaid TF
    Drug Metab Pers Ther; 2018 Mar; 33(1):57-60. PubMed ID: 29470173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y; Naito T; Onodera M; Kuroha M; Kimura T; Shiga H; Endo K; Negoro K; Kinouchi Y; Shimosegawa T
    Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
    Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
    Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
    Kang B; Kim TJ; Choi J; Baek SY; Ahn S; Choi R; Lee SY; Choe YH
    Aliment Pharmacol Ther; 2020 Aug; 52(3):459-470. PubMed ID: 32598049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.
    Zhu X; Wang XD; Chao K; Zhi M; Zheng H; Ruan HL; Xin S; Ding N; Hu PJ; Huang M; Gao X
    Aliment Pharmacol Ther; 2016 Nov; 44(9):967-975. PubMed ID: 27604507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease.
    Chao K; Huang Y; Zhu X; Tang J; Wang X; Lin L; Guo H; Zhang C; Li M; Yang Q; Huang J; Ye L; Hu P; Huang M; Cao Q; Gao X
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1124-1133. PubMed ID: 34563096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of
    Kojima Y; Hirotsu Y; Omata W; Sugimori M; Takaoka S; Ashizawa H; Nakagomi K; Yoshimura D; Hosoda K; Suzuki Y; Mochizuki H; Omata M
    World J Gastroenterol; 2018 Jan; 24(4):511-518. PubMed ID: 29398872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis.
    Miao Q; Yan L; Zhou Y; Li Y; Zou Y; Wang L; Bai Y; Zhang J
    Sci Rep; 2021 Apr; 11(1):7984. PubMed ID: 33846471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of Azathioprine-induced leukopenia in an European woman.
    Séverine W; Xavier K; Jean-Charles C
    Acta Clin Belg; 2022 Feb; 77(1):163-167. PubMed ID: 32842934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease.
    Jena A; Grover N; Bhatia P; Singh M; Lad D; Prasad KK; Singh H; Dutta U; Sharma V
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):25-30. PubMed ID: 36707393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.
    Ban H; Andoh A; Tanaka A; Tsujikawa T; Sasaki M; Saito Y; Fujiyama Y
    Intern Med; 2008; 47(19):1645-8. PubMed ID: 18827410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
    Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
    Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.